Brief: Organon To Pay Sun Pharmaceutical $120 Mln Termination Fee If Deal Terminated
27/04/2026 11:40
April 27 (Reuters) - Organon & Co OGN.N: ORGANON & CO - IF DEAL TERMINATED UNDER CERTAIN CIRCUMSTANCES, CO TO PAY SUN PHARMACEUTICAL HOLDINGS USA TERMINATION FEE OF $120 MILLION - SEC FILING Source text: [ID:n0001193125-26-178718] Further company coverage: OGN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary